142 related articles for article (PubMed ID: 20670084)
1. Use of rituximab in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma in a mycophenolate mofetil treated patient with lupus nephritis.
Lai GG; Koo YX; Tao M; Tan TT; Lim ST
Acta Oncol; 2011 Jan; 50(1):144-5. PubMed ID: 20670084
[No Abstract] [Full Text] [Related]
2. Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature.
Balci MA; Pamuk GE; Unlu E; Usta U; Pamuk ON
Lupus; 2017 Oct; 26(11):1224-1227. PubMed ID: 28152659
[TBL] [Abstract][Full Text] [Related]
3. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
[TBL] [Abstract][Full Text] [Related]
4. Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus.
Tsang HH; Trendell-Smith NJ; Wu AK; Mok MY
Lupus; 2010 Mar; 19(3):330-3. PubMed ID: 19897521
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system lymphoma associated with mycophenolate mofetil in lupus nephritis.
Dasgupta N; Gelber AC; Racke F; Fine DM
Lupus; 2005; 14(11):910-3. PubMed ID: 16335585
[TBL] [Abstract][Full Text] [Related]
6. Recent clinical trials in lupus nephritis.
Ward MM
Rheum Dis Clin North Am; 2014 Aug; 40(3):519-35, ix. PubMed ID: 25034160
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
8. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
[TBL] [Abstract][Full Text] [Related]
9. [Lupus nephritis, mycophenolate, and cytomegalovirus infection].
Sánchez de la Nieta MD; Carreño A; de la Torre M; Rivera F
Nefrologia; 2006; 26(1):141-2. PubMed ID: 16649438
[No Abstract] [Full Text] [Related]
10. Primary lymphoma of CNS, mycophenolate mofetil and lupus.
Finelli PF; Naik K; DiGiuseppe JA; Prasad A
Lupus; 2006; 15(12):886-8. PubMed ID: 17211996
[TBL] [Abstract][Full Text] [Related]
11. Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
Guirguis HR; Cheung MC; Mahrous M; Piliotis E; Berinstein N; Imrie KR; Zhang L; Buckstein R
Br J Haematol; 2012 Oct; 159(1):39-49. PubMed ID: 22849793
[TBL] [Abstract][Full Text] [Related]
12. Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study.
Boletis JN; Marinaki S; Skalioti C; Lionaki SS; Iniotaki A; Sfikakis PP
Nephrol Dial Transplant; 2009 Jul; 24(7):2157-60. PubMed ID: 19179411
[TBL] [Abstract][Full Text] [Related]
13. Cost comparison between mycophenolate mofetil and cyclophosphamide-azathioprine in the treatment of lupus nephritis.
Tse KC; Tang CS; Lam MF; Yap DY; Chan TM
J Rheumatol; 2009 Jan; 36(1):76-81. PubMed ID: 19004041
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.
Lanata CM; Mahmood T; Fine DM; Petri M
Lupus; 2010 Jul; 19(8):935-40. PubMed ID: 20388722
[TBL] [Abstract][Full Text] [Related]
15. An unexpected trismus.
Alves M; Canoui E; Deforges L; Garderet L; Guidet B; Offenstadt G; Maury E
Lancet; 2012 Aug; 380(9840):536. PubMed ID: 22863054
[No Abstract] [Full Text] [Related]
16. Mycophenolate mofetil for lupus nephritis.
McCune WJ
N Engl J Med; 2005 Nov; 353(21):2282-4. PubMed ID: 16306526
[No Abstract] [Full Text] [Related]
17. Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.
Burchardi C; Schlöndorff D
Nat Clin Pract Nephrol; 2006 Jun; 2(6):314-5. PubMed ID: 16932452
[No Abstract] [Full Text] [Related]
18. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
[TBL] [Abstract][Full Text] [Related]
19. [Cryptococcal osteomyelitis in a patient with a lymphocytic leukemia treated with fludarabine-cyclophosphamide-rituximab].
Ettahar N; Legout L; Ajana F; Patoz P; Massongo M; Rose C; Senneville E
J Mycol Med; 2013 Mar; 23(1):57-63. PubMed ID: 23375857
[TBL] [Abstract][Full Text] [Related]
20. [Recent investigations on the basis of pathogenesis of SLE and new therapeutic approaches].
Watanabe N; Takabayashi K
Nihon Rinsho; 2009 Mar; 67(3):500-5. PubMed ID: 19280923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
